⚖ Oral Arguments, with Context

Real court arguments, crisp audio, with context.

Court recordings can be difficult to follow, and many suffer from poor audio quality. This podcast enhances the audio, provides a brief introduction to each case, and explains legal concepts that may be unfamiliar to some listeners.

We hope these enhancements make oral argument recordings easier to understand, more accessible, and more enjoyable to listen to.

Apple Podcasts Spotify YouTube /feed.xml Open RSS

United States ex rel. Pacira BioSciences, Inc. v. QuVa Pharma, Inc. — 1st Cir. (argued September 10, 2026)

No. 25-1973 Argued September 10, 2026 Published September 11, 2026

The First Circuit reviews the dismissal of Pacira BioSciences' qui tam False Claims Act suit. A qui tam relator sues in the United States' name. Pacira alleges that several companies induced health-care providers to seek federal reimbursement for compounded postoperative pain drugs that did not meet federal requirements. Materiality asks whether the alleged falsehood could influence payment. Continued payment despite actual knowledge can be strong evidence against materiality, but it is not automatically decisive. The appeal also raises the public-disclosure bar and Rule 9(b), which requires alleged fraud to be stated with particularity.

United States ex rel. Pacira BioSciences, Inc. v. QuVa Pharma, Inc. (No. 25-1973) — U.S. Court of Appeals for the First Circuit, argued September 10, 2026.

Sources
Argument audio — U.S. Court of Appeals for the First Circuit (public domain, 17 U.S.C. § 105):https://www.ca1.uscourts.gov/sites/ca1/files/oralargs/25-1973_20260910.mp3
Argument listing — U.S. Court of Appeals for the First Circuit:https://www.ca1.uscourts.gov/doar/results/2026-09
September 2026 argument calendar — U.S. Court of Appeals for the First Circuit:https://www.ca1.uscourts.gov/sites/ca1/files/calendar.pdf?simple=True
Appellate docket — Justia:https://dockets.justia.com/docket/circuit-courts/ca1/25-1973
First amended complaint — U.S. District Court record via Docket Alarm:https://www.docketalarm.com/cases/Massachusetts_District_Court/1--23-cv-10135/United_States_of_America_et_al_v._Nephron_Sterile_Compounding_Center_LLC_et_al/32/
District-court docket — U.S. District Court record via Docket Alarm:https://www.docketalarm.com/cases/Massachusetts_District_Court/1--23-cv-10135/United_States_of_America_et_al_v._Nephron_Sterile_Compounding_Center_LLC_et_al/
Dismissal order entry — U.S. District Court record via Docket Alarm:https://www.docketalarm.com/cases/Massachusetts_District_Court/1--23-cv-10135/United_States_of_America_et_al_v._Nephron_Sterile_Compounding_Center_LLC_et_al/149/
31 U.S.C. § 3729 — U.S. House Office of the Law Revision Counsel:https://uscode.house.gov/view.xhtml?req=%28title%3A31+section%3A3729+edition%3Aprelim%29
31 U.S.C. § 3730 — U.S. House Office of the Law Revision Counsel:https://uscode.house.gov/view.xhtml?edition=prelim&hl=false&num=0&req=granuleid%3AUSC-prelim-title31-section3730
False Claims Act overview — U.S. Department of Justice:https://www.justice.gov/civil/false-claims-act
Universal Health Services v. Escobar — U.S. Reports via GovInfo:https://www.govinfo.gov/content/pkg/USREPORTS-579/pdf/USREPORTS-579-176.pdf
Escobar on remand — U.S. Court of Appeals for the First Circuit:https://media.ca1.uscourts.gov/pdf.opinions/14-1423P-01A.pdf
Public-disclosure precedent — U.S. Court of Appeals for the First Circuit:https://media.ca1.uscourts.gov/pdf.opinions/15-1991P-01A.pdf
Federal Rules of Civil Procedure — U.S. Courts:https://www.uscourts.gov/sites/default/files/document/federal-rules-of-civil-procedure.pdf
Rule 9(b) precedent — U.S. Court of Appeals for the First Circuit:https://media.ca1.uscourts.gov/pdf.opinions/12-1867P-01A.pdf
Imad Matini — court filing:https://cases.justia.com/federal/district-courts/california/caedce/2%3A2025mc00367/474301/8/0.pdf
Imad Matini — professional profile:https://wvexecutive.com/imad-matini/
Allon Kedem — Arnold & Porter:https://www.arnoldporter.com/en/people/k/kedem-allon
Allon Kedem — U.S. Supreme Court filing:https://www.supremecourt.gov/DocketPDF/25/25-1018/404542/20260415132615116_25-1018--PhRMA%20Letter%20Opposing%20XT%2004-15%20rtf.pdf
Carrie Richey — Womble Bond Dickinson:https://www.womblebonddickinson.com/us/people/carrie-richey
Carrie Richey — filed appellate brief:https://images.law.com/contrib/content/uploads/documents/403/57732/SAS-v.-World-Programming.SAS-opening-brief-on-appeal-1.pdf
John C. Neiman Jr. — Maynard Nexsen:https://www.maynardnexsen.com/capabilities-appellate-and-post-verdict
John C. Neiman Jr. — federal appellate opinion via GovInfo:https://www.govinfo.gov/content/pkg/USCOURTS-ca6-24-05603/pdf/USCOURTS-ca6-24-05603-0.pdf

0:00
0:00